Table 1.

Heart Transplant Recipient Characteristics, by Race.

Variable	Black* (n= 4,594)	non-Black† (n= 18,403)	p-value
Age, median (IQR)	51 (18–59)	57 (48–63)	<0.001
Female (%)	33.6	23.0	<0.001
Insurance			<0.001
Medicaid (%)	20.2	10.1
Medicare (%)	36.3	32.5
Private (%)	38.9	53.8
Other (%)	4.6	3.7
Dialysis (%)	2.3	1.7	<0.05
College education (%)	44.0	50.2	<0.001
Diagnosis			<0.001
Cardiomyopathy (%)	95.0	90.0
Ischemic dilated (%)‡	19.1	39.6
Non-ischemic dilated (%)‡	72.0	44.6
Restrictive (%)‡	2.9	2.8
Hypertrophic (%)‡	1.0	2.7
Congenital heart disease (%)	1.0	3.3
Coronary heart disease (%)	1.9	4.3
Other	2.1	2.8
Hypertension	44.1	38.5	<0.001
Diabetes mellitus	25.3	25.2	0.8
HLA mismatch§	66.6	57.4	<0.001
Immunosuppression induction			<0.001
None	46.7	49.5
Thymoglobulin	14.9	14.9
IL-2	31.0	27.7
Other, multiple agents	7.4	7.9
Immunosuppression maintenance
Tacrolimus	86.6	80.6	<0.001
Mycophenolate mofetil	94.0	93.3	<0.05
Steroids	91.6	92.0	0.3
Era of transplant: 2012–2017	50.0	45.9	<0.001

^*Black=Black or African American.

^†non-Black included Caucasian (84.8%), Hispanic/Latino (9.9%), Asian (4.0%), American Indian or Alaska Native (0.4%), Native Hawaiian (0.4%), or other/unspecified (0.5%).

^‡Percentage of all listed diagnoses. HLA = human leukocyte antigen;

^§HLA mismatch defined as ≥ 5 antigen mismatches.